Commission launches consultation on responsible nano research

The European Commission has launched a consultation on responsible research in nanosciences and nanotechnologies.

The consultation is part of the Commission's plan to suggest that the EU Member States sign up to a Code of Conduct for this emerging area of science. A broad spectrum of society is addressed by the consultation, from the scientific community and industry to civil society, policy-makers, media and the general public.

"Nanosciences and nanotechnologies have the potential to drive growth and jobs in Europe, and their development and use should not be delayed, unbalanced or left to chance," said EU Science and Research Commissioner Janez Potocnik. "It is important that we pursue this knowledge with full understanding of the possible implications of these new areas of science, and that we do so openly and involving all concerned."

The Commissioner also stressed that the consultation demonstrates the Commission's commitment to 'developing the potential of nanosciences with appropriate safeguards'.

Estimates as to the market potential of nanotechnology products vary, but are all very positive. The Mitsubishi Institute estimated in 2002 that the market would be worth USD 150 billion (around €110 billion) by 2010, while in 2004 the Lux Research group predicted that the market would be worth USD 2.6 trillion (around €1.9 trillion) by 2014.

If this latter estimate is proved to be accurate, it will mean the nanoscience and nanotechnology market overtaking the information and communication technologies (ICT) market, and growing to 10 times the size of the biotechnology market.

However, concerns over safety have put the brakes on some research into the nanosciences and nanotechnologies. The principal concerns cover the ability of nanoparticles to cross natural bio-boundaries, and the prospect of connecting living creatures and human-made materials and systems.

These concerns have led to the development of a new area of research: the responsible management and control of nanosciences. This involves ethics, safety, the environment, individual rights, and the protection of personal data.

The Code of Conduct would encompass basic principles on which to base future developments in nano research, and would invite signatories to take concrete action to ensure that nanotechnologies are developed in a safe manner.

The consultation will close on 21 September.

For further information, please visit:
http://europa.eu/sinapse/directaccess/
science-and-society/public-debates/nano-recommendation/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...